|
US4631190A
(en)
|
1981-06-26 |
1986-12-23 |
Shen Wei C |
Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers
|
|
US5217999A
(en)
|
1987-12-24 |
1993-06-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
|
|
FI924427L
(fi)
|
1990-04-02 |
1992-10-01 |
Pfizer |
Bensylfosfonsyratyrosinkinas-inhibitorer
|
|
US5302606A
(en)
|
1990-04-16 |
1994-04-12 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
|
|
ATE159009T1
(de)
|
1991-05-10 |
1997-10-15 |
Rhone Poulenc Rorer Int |
Bis mono- und bicyclische aryl- und heteroarylderivate mit inhibierender wirkung auf die egf und/oder pdgf-rezeptor tyrosinkinase
|
|
US6194439B1
(en)
|
1991-05-29 |
2001-02-27 |
Pfizer Inc. |
Tricyclic polyhydroxylic tyrosine kinase inhibitors
|
|
GB9300059D0
(en)
|
1992-01-20 |
1993-03-03 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US5936079A
(en)
|
1992-04-06 |
1999-08-10 |
Alton Ochsner Medical Foundation |
Oligonucleotide which binds to a chromosomal binding site for p53 protein
|
|
RU2155187C2
(ru)
|
1992-08-06 |
2000-08-27 |
Варнер-Ламберт Компани |
Производные индола, их таутомеры, смеси их изомеров или отдельные изомеры и фармацевтически приемлемые соли, фармацевтическая композиция с антиопухолевой или ингибирующей протеин-тирозинкиназу активностью и способ торможения зависящего от протеин-тирозинкиназы заболевания или борьбы с аберрантным ростом клеток млекопитающего или человека.
|
|
US5330992A
(en)
|
1992-10-23 |
1994-07-19 |
Sterling Winthrop Inc. |
1-cyclopropyl-4-pyridyl-quinolinones
|
|
GB9226855D0
(en)
|
1992-12-23 |
1993-02-17 |
Erba Carlo Spa |
Vinylene-azaindole derivatives and process for their preparation
|
|
US5565215A
(en)
*
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
WO1995024190A2
(en)
|
1994-03-07 |
1995-09-14 |
Sugen, Inc. |
Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
|
|
GB9412719D0
(en)
|
1994-06-24 |
1994-08-17 |
Erba Carlo Spa |
Substituted azaindolylidene compounds and process for their preparation
|
|
US5972707A
(en)
|
1994-06-27 |
1999-10-26 |
The Johns Hopkins University |
Gene delivery system
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US6610832B1
(en)
|
1995-03-23 |
2003-08-26 |
Biopure Corporation |
Preserving a hemoglobin blood substitute with a transparent overwrap
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US6034081A
(en)
|
1995-05-30 |
2000-03-07 |
Buckman Laboratories International Inc |
Potentiation of biocide activity using an N-alkyl heterocyclic compound
|
|
US5693631A
(en)
|
1995-05-30 |
1997-12-02 |
Buckman Laboratories International, Inc. |
Potentiation of the microbicide 2-(thiocyanomethylthio) benzothiazole using an N-alkyl heterocyclic compound
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
|
US5596878A
(en)
|
1995-06-26 |
1997-01-28 |
Thermo King Corporation |
Methods and apparatus for operating a refrigeration unit
|
|
AR004010A1
(es)
|
1995-10-11 |
1998-09-30 |
Glaxo Group Ltd |
Compuestos heterociclicos
|
|
FR2749853B1
(fr)
|
1996-06-12 |
1998-10-16 |
Rhone Poulenc Chimie |
Formulation amelioree a base d'un compose hydroxyle et d'un compose amphiphile complexant utilisable notamment pour modifier les proprietes rheologiques d'emulsions
|
|
ID19430A
(id)
|
1996-07-13 |
1998-07-09 |
Glaxo Group Ltd |
Senyawa senyawa heterosiklik
|
|
AR007857A1
(es)
|
1996-07-13 |
1999-11-24 |
Glaxo Group Ltd |
Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen.
|
|
US5948878A
(en)
|
1997-04-15 |
1999-09-07 |
Burgess; Stephen W. |
Cationic polymers for nucleic acid transfection and bioactive agent delivery
|
|
DE69819343T2
(de)
|
1997-08-27 |
2004-07-22 |
California Institute Of Technology, Pasadena |
Zusammensetzungen und ihre verwendung zur verhütung von verklebungen zwischen körpergewebe
|
|
US6225346B1
(en)
|
1997-10-24 |
2001-05-01 |
Sugen, Inc. |
Tyrphostin like compounds
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
US6048736A
(en)
|
1998-04-29 |
2000-04-11 |
Kosak; Kenneth M. |
Cyclodextrin polymers for carrying and releasing drugs
|
|
US7091192B1
(en)
|
1998-07-01 |
2006-08-15 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
|
WO2000010007A2
(en)
|
1998-08-17 |
2000-02-24 |
California Institute Of Technology |
Devices and methods for analysis of non-ionic solutes
|
|
WO2000012146A1
(en)
|
1998-08-27 |
2000-03-09 |
Eidgenössisch Technische Hochschule Zurich |
Gels and multilayer surface structures from boronic acid containing polymers
|
|
UA71945C2
(en)
|
1999-01-27 |
2005-01-17 |
Pfizer Prod Inc |
Substituted bicyclic derivatives being used as anticancer agents
|
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
|
US7087613B2
(en)
|
1999-11-11 |
2006-08-08 |
Osi Pharmaceuticals, Inc. |
Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
|
|
PE20011178A1
(es)
|
2000-04-07 |
2001-11-19 |
Takeda Chemical Industries Ltd |
Compuestos heterociclicos y su produccion
|
|
US6372250B1
(en)
|
2000-04-25 |
2002-04-16 |
The Regents Of The University Of California |
Non-invasive gene targeting to the brain
|
|
US6335342B1
(en)
|
2000-06-19 |
2002-01-01 |
Pharmacia & Upjohn S.P.A. |
Azaindole derivatives, process for their preparation, and their use as antitumor agents
|
|
KR100545537B1
(ko)
|
2000-06-22 |
2006-01-25 |
화이자 프로덕츠 인코포레이티드 |
비정상적 세포 성장 치료용의 치환된 이환식 유도체
|
|
CN1305872C
(zh)
|
2000-06-30 |
2007-03-21 |
葛兰素集团有限公司 |
喹唑啉类化合物的制备方法
|
|
TWI321054B
(en)
|
2000-12-19 |
2010-03-01 |
California Inst Of Techn |
Compositions containing inclusion complexes
|
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
US7041280B2
(en)
|
2001-06-29 |
2006-05-09 |
Genzyme Corporation |
Aryl boronate functionalized polymers for treating obesity
|
|
EP1990040A1
(en)
|
2001-07-10 |
2008-11-12 |
North Carolina State University |
Nanoparticle delivery vehicle
|
|
IL160010A0
(en)
|
2001-07-23 |
2004-06-20 |
Univ Ramot |
Methods and compositions for treating fungal infections
|
|
WO2003011943A1
(en)
|
2001-07-30 |
2003-02-13 |
California Institute Of Technology |
Synthesis of substituted poly(aniline)s
|
|
AU2002323501C1
(en)
|
2001-08-30 |
2010-04-29 |
Biorexis Technology, Inc |
Modified transferrin fusion proteins
|
|
EP1439178A4
(en)
|
2001-10-05 |
2005-11-16 |
Takeda Pharmaceutical |
Heterocyclic compounds, oxazole derivatives, process for their preparation and their use
|
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
BR0214499A
(pt)
|
2001-12-12 |
2005-05-10 |
Pfizer Prod Inc |
Derivados de quinazolina para o tratamento do crescimento anormal das células
|
|
JP4202926B2
(ja)
|
2001-12-12 |
2008-12-24 |
ファイザー・プロダクツ・インク |
Ｅ−２−メトキシ−ｎ−（３−（４−（３−メチル−ピリジン−３−イロキシ）−フェニルアミノ）−キナゾリン−６−イル）−アリル）−アセトアミドの塩形態、その製造および癌に対するその使用
|
|
WO2003053446A1
(en)
|
2001-12-19 |
2003-07-03 |
Smithkline Beecham Corporation |
Thienopyrimidine compounds as protein tyrosine kinase inhibitors
|
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
|
US7094427B2
(en)
|
2002-05-29 |
2006-08-22 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
|
AU2003241898A1
(en)
|
2002-06-03 |
2003-12-19 |
Mitsubishi Pharma Corporation |
PREVENTIVES AND/OR REMEDIES FOR SUBJECTS WITH THE EXPRESSION OR ACTIVATION OF Her2 AND/OR EGFR
|
|
AU2003278764C1
(en)
|
2002-09-06 |
2010-09-16 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
CA2546696A1
(en)
|
2002-11-19 |
2004-06-03 |
Genzyme Corporation |
Polymeric boronic acid derivatives as lipase inhibitors
|
|
AU2003298749A1
(en)
|
2002-11-26 |
2004-06-18 |
Seacoast Neuroscience, Inc. |
Buoyant polymer particles delivering therapeutic agents
|
|
ES2410814T3
(es)
|
2003-01-29 |
2013-07-03 |
Takeda Pharmaceutical Company Limited |
Compuestos de tienopirimidina y uso de los mismos
|
|
JP2005119255A
(ja)
|
2003-10-17 |
2005-05-12 |
San Quest:Kk |
携帯電話画像取り込み機能付き名刺印刷装置
|
|
US20050090732A1
(en)
|
2003-10-28 |
2005-04-28 |
Triton Biosystems, Inc. |
Therapy via targeted delivery of nanoscale particles
|
|
US7399645B2
(en)
|
2004-05-12 |
2008-07-15 |
Applera Corporation |
Constrained cis-diol-borate bioconjugation system
|
|
US7943713B2
(en)
|
2004-07-30 |
2011-05-17 |
Basf Aktiengesellschaft |
Polymeric boronic acid derivatives and their use for papermaking
|
|
US7413173B2
(en)
|
2004-09-10 |
2008-08-19 |
Ric Investments, Llc |
Molded water chamber base plate for use in a humidifier and ventilator assembly
|
|
WO2006044275A2
(en)
|
2004-10-12 |
2006-04-27 |
Luminex Corporation |
Methods for altering surface characteristics of microspheres
|
|
TW200618820A
(en)
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
|
PL1866414T3
(pl)
|
2005-03-31 |
2012-10-31 |
Calando Pharmaceuticals Inc |
Inhibitory podjednostki 2 reduktazy rybonukleotydowej i ich zastosowania
|
|
US20060246524A1
(en)
|
2005-04-28 |
2006-11-02 |
Christina Bauer |
Nanoparticle conjugates
|
|
US9062126B2
(en)
|
2005-09-16 |
2015-06-23 |
Raptor Pharmaceuticals Inc. |
Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
|
|
US20080267876A1
(en)
|
2005-09-20 |
2008-10-30 |
Yissum Research Development Company |
Nanoparticles for Targeted Delivery of Active Agent
|
|
US7988988B2
(en)
|
2005-11-21 |
2011-08-02 |
Bausch & Lomb Incorporated |
Contact lenses with mucin affinity
|
|
EP2046266A4
(en)
|
2006-07-21 |
2009-11-04 |
Massachusetts Inst Technology |
ENDMODICIFIED POLY (BETA AMINO ESTER) AND ITS USE
|
|
EP2054043A2
(en)
|
2006-08-17 |
2009-05-06 |
Novartis AG |
Nanoparticle compositions
|
|
US8425887B2
(en)
|
2006-09-29 |
2013-04-23 |
Genzyme Corporation |
Amide dendrimer compositions
|
|
US7825127B2
(en)
|
2006-12-28 |
2010-11-02 |
Takeda Pharmaceutical Company, Limited |
Method for treating cancer
|
|
WO2009036022A1
(en)
|
2007-09-10 |
2009-03-19 |
Board Of Regents, The University Of Texas System |
Enhancement of polysaccharide-mediated nucleic acid delivery
|
|
KR101451564B1
(ko)
|
2007-12-28 |
2014-11-04 |
임팩스 라보라토리즈, 인코포레이티드 |
레보도파 방출 제어형 제제 및 이의 용도
|
|
US20100029545A1
(en)
|
2008-08-04 |
2010-02-04 |
Sumerlin Brent S |
Boronic acid-containing block copolymers for controlled drug delivery
|
|
WO2010019718A2
(en)
*
|
2008-08-13 |
2010-02-18 |
California Institute Of Technology |
Carrier nanoparticles and related compositions, methods and systems
|
|
US8367166B2
(en)
|
2008-10-31 |
2013-02-05 |
Chevron U.S.A. Inc. |
Synthesis of higher diamondoids
|
|
US20120156138A1
(en)
|
2009-04-14 |
2012-06-21 |
Smith Larry J |
Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
|
|
CN102481375B
(zh)
|
2009-05-27 |
2017-06-06 |
西莱克塔生物科技公司 |
具有不同释放速率的纳米载体加工组分
|
|
FR2946476B1
(fr)
|
2009-06-05 |
2014-03-21 |
Aeg Power Solutions Bv |
Convertisseur continu-continu a regulation double alternance
|
|
US20100330686A1
(en)
|
2009-06-29 |
2010-12-30 |
Seung Bum Park |
Nanosensor for sugar detection
|
|
CN102906127A
(zh)
|
2009-11-06 |
2013-01-30 |
华盛顿大学商业中心 |
来自两性离子聚合物的自组装颗粒以及相关的方法
|
|
US9138418B2
(en)
|
2009-12-09 |
2015-09-22 |
William Marsh Rice University |
Therapeutic compositions and methods for delivery of active agents cleavably linked to nanoparticles
|
|
CN103002919B
(zh)
|
2010-02-04 |
2015-03-25 |
得克萨斯系统大学评议会 |
纳米聚合物对免疫调节剂的肿瘤靶向递送
|
|
ES2600005T3
(es)
|
2010-06-18 |
2017-02-06 |
Universiteit Twente |
Polímeros boronados
|
|
CA2808901A1
(en)
|
2010-08-20 |
2012-02-23 |
Cerulean Pharma Inc. |
Conjugates, particles, compositions, and related methods
|
|
US20120148489A1
(en)
|
2010-12-10 |
2012-06-14 |
California Institute Of Technology |
Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
|
|
WO2012158622A2
(en)
|
2011-05-13 |
2012-11-22 |
The Regents Of The University Of California |
Reversibly crosslinked micelle systems
|
|
DE102012017025B4
(de)
|
2012-08-28 |
2018-05-30 |
Kennametal Inc. |
Werkzeughalter für einen Schneideinsatz und Baugruppe mit einem solchen Werkzeughalter
|
|
GB201220474D0
(en)
|
2012-11-14 |
2012-12-26 |
Sagetis Biotech Sl |
Polypeptides
|
|
EP2961395B1
(en)
|
2013-03-01 |
2024-06-19 |
California Institute Of Technology |
Targeted nanoparticles
|
|
JP6251295B2
(ja)
*
|
2013-03-01 |
2017-12-20 |
カリフォルニア インスティテュート オブ テクノロジー |
ニトロフェニルボロン酸組成物によって安定化したナノ粒子
|
|
US9132097B2
(en)
*
|
2013-03-01 |
2015-09-15 |
California Institute Of Technology |
Nanoparticles stabilized with nitrophenylboronic acid compositions
|
|
US9468681B2
(en)
|
2013-03-01 |
2016-10-18 |
California Institute Of Technology |
Targeted nanoparticles
|
|
EP2997070A4
(en)
|
2013-05-14 |
2016-12-14 |
California Inst Of Techn |
METHOD FOR THE DELIVERY OF THERAPEUTIC AND CONTRASTANTS THROUGH NANOPARTICLES THAT GO THROUGH THE BLOOD-BRAIN-BARRIER
|
|
WO2016037166A1
(en)
|
2014-09-07 |
2016-03-10 |
Yu Zhang |
Novel anti-oxidant compositions and methods of delivery
|
|
ES2980216T3
(es)
|
2015-07-01 |
2024-09-30 |
California Inst Of Techn |
Sistemas de administración basados en polímeros de ácido múcico catiónicos
|